You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carfentanil

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)

Not yet recruiting
  • Opioid Use Disorder
  • New Haven, Connecticut
    New Haven, Connecticut
Jan 18, 2023

Obesity Trial in Turku (fMRI imaging, [11C]carfentanil PET scan, [18F]FMPEP-d2 PET scan)

Active, not recruiting
  • Obesity
  • fMRI imaging
  • +7 more
  • Turku, Finland
    Turku PET Centre (Turku University Hospital)
Dec 16, 2021

Neuralgia Trial in Aarhus (procedure, device, drug)

Terminated
  • Neuralgia
  • Deep brain stimulation
  • +2 more
  • Aarhus, Region Midtjylland, Denmark
    Aarhus University Hospital
Sep 13, 2021

Smoking, Cannabis Trial in New Haven (cannabis)

Recruiting
  • Smoking
  • Cannabis
  • New Haven, Connecticut
  • +2 more
Dec 6, 2022

Pain Trial in Houston (anakinra, Placebo, Nociceptive pain challenge)

Recruiting
  • Pain
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jan 19, 2022

Obesity, Morbid, Insulin Resistance Trial in Turku (Bariatric surgery)

Active, not recruiting
  • Obesity, Morbid
  • Insulin Resistance
  • Bariatric surgery
  • Turku, Finland
    Turku PET Centre
Oct 12, 2021

Healthy Subjects, Opioid Antagonist, Pharmacokinetics Trial in West Bend (Four naloxone nasal spray doses (1 every 2.5 min),

Completed
Has Results
  • Healthy Subjects
  • +2 more
  • Four naloxone nasal spray doses (1 every 2.5 min)
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Mar 17, 2022

Brain Function, Body Metabolism and Their Interaction

Recruiting
  • Anorexia Nervosa
    • Turku, Finland
      Turku PET Centre
    Nov 1, 2021

    Physical Exercise Behavior (Liking/Aversion) Trial in Turku (Exercise)

    Completed
    • Physical Exercise Behavior (Liking/Aversion)
    • Exercise
    • Turku, Finland
      Turku PET Centre
    Mar 4, 2021

    Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,

    Recruiting
    • Sleep Disorder
    • Healthy
    • Sleep Fragmentation
    • +3 more
    • Baltimore, Maryland
      Johns Hopkins School of Medicine
    Nov 14, 2022

    Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)

    Not yet recruiting
    • Alcohol Use Disorder
    • Detoxification Program
    • +2 more
    • (no location specified)
    Jul 13, 2023

    MDD Trial in Salt Lake City (Duloxetine, Placebo)

    Not yet recruiting
    • Major Depressive Disorder
    • Salt Lake City, Utah
      University of Utah
    Apr 21, 2021

    Endogenous Opioid Systems and Symptom Change in Fibromyalgia

    Not yet recruiting
    • Fibromyalgia
    • No treatment
    • (no location specified)
    Apr 21, 2021

    HIV Trial in Baltimore (CHECKIT!)

    Recruiting
    • HIV Infections
    • CHECKIT!
    • Baltimore, Maryland
      Johns Hopkins School of Public Health
    Aug 3, 2023

    Substance-related Discorder Trial in Baltimore (Nicotine, Carfentanil)

    Completed
    • Substance-related Discorder
    • Baltimore, Maryland
    • +1 more
    Apr 4, 2018

    Endogenous Opioid Mechanisms for Rejection Sensitivity

    Completed
    • Rejection Sensitivity
      • Ann Arbor, Michigan
        University of Michigan
      Oct 19, 2020

      Pain Trial in La Jolla, San Diego (behavioral, drug, other)

      Completed
      • Pain
      • Mindfulness
      • +3 more
      • La Jolla, California
      • +1 more
      Feb 4, 2022

      Temporomandibular Joint Disorders Trial (High-Definition Transcranial Direct Current Stimulation (HD-tDCS))

      Completed
      Has Results
      • Temporomandibular Joint Disorders
      • High-Definition Transcranial Direct Current Stimulation (HD-tDCS)
      • (no location specified)
      Mar 23, 2020

      Effects of Nicotine on Brain Opioid Receptors

      Terminated
      • Nicotine Dependence
      • Philadelphia, Pennsylvania
        Center for Interdisciplinary Research on Nicotine Addiction, Uni
      Apr 9, 2019

      Obesity Trial in London (Part A Assessing GSK1521498, Part B Assessing GSK1521498, Part C Assessing Naltrexone)

      Completed
      • Obesity
      • Part A Assessing GSK1521498
      • +2 more
      • London, United Kingdom
        GSK Investigational Site
      Jun 19, 2017

      Obesity Trial in Ann Arbor (Very Low Calorie Diet (VLCD))

      Completed
      • Obesity
      • Very Low Calorie Diet (VLCD)
      • Ann Arbor, Michigan
        University of Michigan Medical School
      Sep 20, 2018

      Nicotine Dependence Trial in Baltimore (Nicotine patch - transdermal, )

      Completed
      Has Results
      • Nicotine Dependence
      • Nicotine patch - transdermal
      • placebo
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Apr 18, 2019

      Trigeminal Neuropathic Pain Trial in Ann Arbor (PET Scans, transcranial direct current stimulation (tDCS), MRI)

      Completed
      • Trigeminal Neuropathic Pain
      • PET Scans
      • +3 more
      • Ann Arbor, Michigan
        University of Michigan
      Nov 21, 2017

      Depression Trial in Ann Arbor (Placebo, identified as to participants, Celexa or other antidepressant as clinically indicated,

      Completed
      Has Results
      • Depression
      • Placebo, identified as placebo to participants
      • +2 more
      • Ann Arbor, Michigan
        Department of Psychiatry
      Oct 31, 2017

      Morbid Obesity Trial in Turku (Bariatric surgery)

      Completed
      • Morbid Obesity
      • Bariatric surgery
      • Turku, Finland
        Turku PET Centre
      Mar 5, 2017